Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ null Mouse Model of Malaria

J Med Chem. 2018 May 10;61(9):4213-4227. doi: 10.1021/acs.jmedchem.8b00382. Epub 2018 Apr 27.

Abstract

Optimization of a chemical series originating from whole-cell phenotypic screening against the human malaria parasite, Plasmodium falciparum, led to the identification of two promising 2,6-disubstituted imidazopyridine compounds, 43 and 74. These compounds exhibited potent activity against asexual blood stage parasites that, together with their in vitro absorption, distribution, metabolism, and excretion (ADME) properties, translated to in vivo efficacy with clearance of parasites in the PfSCID mouse model for malaria within 48 h of treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Drug Discovery*
  • Drug Stability
  • ERG1 Potassium Channel / metabolism
  • Humans
  • Imidazoles / chemistry*
  • Imidazoles / metabolism
  • Imidazoles / pharmacokinetics*
  • Imidazoles / therapeutic use
  • Malaria / drug therapy*
  • Malaria / genetics
  • Malaria / metabolism
  • Mice
  • Plasmodium falciparum / physiology*
  • Pyridines / chemistry*
  • Pyridines / metabolism
  • Pyridines / pharmacokinetics*
  • Pyridines / therapeutic use
  • Solubility
  • Structure-Activity Relationship
  • Tissue Distribution
  • Water / chemistry

Substances

  • ERG1 Potassium Channel
  • Imidazoles
  • Pyridines
  • imidazopyridine
  • Water